Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

CORONADO, Calif. — Despite recent advances in the treatment of cutaneous squamous cell carcinoma (SCC), a lack of consensus ...

A single-center study suggests the surgery is safe and effective even when tumors are large or located in high-risk areas.

Nearly two months after Randy Moss underwent surgery following his cancer diagnosis, the ESPN commentator made an appearance virtually at the 2025 NFL Honors to present an award.

Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...

In resectable, locally advanced esophageal squamous cell carcinoma, neoadjuvant Tyvyt plus chemoradiotherapy led to an ...

Bladder cancer often begins with subtle symptoms that are easy to overlook. The most common early sign is blood in the urine, a condition known as hematuria. In many cases, the blood may not always be ...

Should I get breast implants? Should they be saline or silicone? Which style? How much monitoring is needed after surgery?

A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck ...

The Au-HN-1 nanosystem represents a breakthrough in TSCC treatment, integrating targeted photothermal therapy with advanced imaging for precise tumor ablation.

A pioneering study has unveiled the Au-HN-1 nanosystem, a cutting-edge approach that promises to transform the diagnosis and treatment of tongue squamous cell carcinoma (TSCC). By harnessing gold ...

Phase 2 trial of defactinib in combination with avutometinib in patients with advanced diffuse-type gastric cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...